ELEVANCE HEALTH, INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$199.12B
Revenue
$5.66B
Net Income
25.19
EPS (Diluted)
$6.60B
Free Cash Flow
Profitability
Gross Margin
89.36%
Operating Margin
-
Net Profit Margin
2.84%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
4.66%
Return on Equity (ROE)
12.90%
Gross Profit
$177.95B
Operating Income
-
Financial Health
Total Assets
$121.49B
Total Debt
$32.05B
Debt to Equity
1.77x
Current Ratio
1.54
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$25.19
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204 |
| Phone | 8003311476 |
| Incorporated | IN, US |
| EIN | 352145715 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $43.88B |
| Cash & Equivalents | $9.49B |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-02
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-06
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
89.4%
Operating Margin
-
Net Margin
2.8%
ROE
12.9%
ROA
4.7%
Leverage & Liquidity
Debt to Equity
1.77
Current Ratio
1.54
Total Debt
$32.05B
Total Assets
$121.49B
Stockholders' Equity
$43.88B
Income Statement (FY 2025)
Revenue
$199.12B
Gross Profit
$177.95B
Operating Income
-
Net Income
$5.66B
EPS (Diluted)
$25.19
Cash Flow (FY 2025)
Free Cash Flow
$6.60B
Cash & Equivalents
$9.49B
Revenue Growth
12.5%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...